ROUGETX LAUNCHES WITH $58 MILLION SERIES A FINANCING TO ADVANCE FIRST-IN-CLASS TREATMENT FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA

Reuters · 2d ago

Please log in to view news